Balyasny Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,200
Closed -$981K 2966
2022
Q3
$981K Buy
15,200
+11,400
+300% +$790K ﹤0.01% 1821
2022
Q2
$263K Buy
+3,800
New +$282K ﹤0.01% 2133
2020
Q4
Sell
-200,000
Closed -$13.3M 1496
2020
Q3
$13.3M Buy
+200,000
New +$12.7M 0.1% 307
2017
Q4
Sell
-475,000
Closed -$17.4M 2157
2017
Q3
$17.4M Buy
+475,000
New +$19.2M 0.07% 356

Other funds holding HOLX

Balyasny Asset Management's HOLX Position: Q1 2026 in Review

Balyasny Asset Management increased its Hologic (HOLX) stake by 194% in Q1 2026, buying an estimated $234M and bringing the position to 4,722,968 shares worth $357M. The position accounts for 0.46% of the portfolio, ranked #28.

Balyasny Asset Management first reported a position in HOLX in Q1 2016 and has held it in 29 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • Balyasny Asset Management held 4,722,968 shares of Hologic worth $357M as of Q1 2026.
  • Balyasny Asset Management bought 3,114,628 Hologic shares in Q1 2026, an estimated $234M.
  • Hologic made up 0.46% of Balyasny Asset Management's portfolio in Q1 2026, its #28 holding.
  • Balyasny Asset Management first reported a position in Hologic in Q1 2016 and has held it in 29 quarters since.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.